Tracers for imaging melanin with positron emission tomography

Area of Science:

• Nuclear medicine
• Radiochemistry
• Ophthalmology

Background:

• Melanin, a pigment, plays a role in various biological processes and is a key component of certain tumors.
• Accurate imaging of melanin-rich tissues, like ocular melanoma, is crucial for diagnosis and treatment monitoring.
• Positron Emission Tomography (PET) offers high sensitivity for detecting radiotracer uptake in vivo.

Purpose of the Study:

• To evaluate the melanin-binding properties of novel radioligands.
• To determine the potential of radiolabeled N-methylspiperone (NMSP) for imaging pigmented tissues, specifically ocular melanoma.
• To assess the feasibility of using PET for detecting melanin-containing structures.

Main Methods:

• In vivo assessment of six radioligands' melanin binding in pigmented and nonpigmented mouse eyes.
• Evaluation of radioligand uptake and signal-to-noise ratios over time.
• A Positron Emission Tomography (PET) study using 11C-N-methylspiperone in a patient with ocular melanoma.

Main Results:

• 3H-N-methylspiperone demonstrated superior uptake and signal-to-noise ratio, with essentially irreversible binding.
• PET imaging revealed increased uptake of 11C-N-methylspiperone in the patient's ocular melanoma.
• The study confirmed the potential of NMSP for targeting melanin.

Conclusions:

• Radiolabeled NMSP is a promising agent for imaging melanin and detecting pigmented ocular melanoma via PET.
• High-resolution PET imaging with NMSP may enable visualization of melanin-containing cells in the substantia nigra.
• This technique could be valuable for studying neurodegenerative diseases like Parkinson's disease.